Updated Jul 16, 2026
FRENKEL JACOB A has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Jacob A. Frenkel is a corporate director who, according to SEC filings, serves as a director of BrainStorm Cell Therapeutics Inc. The most recent filing dated May 29, 2026 lists him in the director role. No additional public biographical details are provided in the SEC filing beyond his board position.
| Role | Director |
|---|---|
| Notability | 25/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-29 | BCLI | BRAINSTORM CELL THERAPEUTICS INC. | A — Grant or award | 200.0K | $0.00 |
Jacob A. Frenkel is a corporate director who, according to SEC filings, serves as a director of BrainStorm Cell Therapeutics Inc. The most recent filing dated May 29, 2026 lists him in the director role. No additional public biographical details are provided in the SEC filing beyond his board position.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live FRENKEL JACOB A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.